awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q34657690-43AD7318-0747-4D8D-8FF4-5B3E50D7FA25
Q34657690-43AD7318-0747-4D8D-8FF4-5B3E50D7FA25
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34657690-43AD7318-0747-4D8D-8FF4-5B3E50D7FA25
Erlotinib usage after prior treatment with gefitinib in advanced non-small cell lung cancer: A clinical perspective and review of published literature.
P2860
Q34657690-43AD7318-0747-4D8D-8FF4-5B3E50D7FA25
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34657690-43AD7318-0747-4D8D-8FF4-5B3E50D7FA25
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ad6e68abd7c1eedc777947c909e0e73894699e14
P2860
Effectiveness of erlotinib in advanced non-small cell lung cancer in cases of gefitinib resistance after treatment of more than 6 months.